Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Clinical trial NCT06830044 · RECRUITING
Trial details
- NCT number
- NCT06830044
- Sponsor
- Vanda Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2028-03-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.